Anne F. Luetkemeyer

Also affiliated with University of California, San Francisco

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections”.

Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections

New England Journal of Medicine(2023)10.1056/nejmoa2211934

N/A

11.9DataRank · unranked

446 citations

Deborah Donnell, Julia C. Dombrowski, Stephanie E. Cohen, Cole Grabow, Clare Brown +12 more

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

New England Journal of Medicine(2020)10.1056/nejmoa2031994

N/A

6.8DataRank · unranked

1924 citations

Thomas F. Patterson, Aneesh K. Mehta, Kay M Tomashek, Cameron R. Wolfe, Varduhi Ghazaryan +55 more

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses

medRxiv(2022)10.1101/2022.07.12.22277336

N/A

1.6DataRank · unranked

30 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00085-4

N/A

1.3DataRank · unranked

40 citations

Deborah Donnell, Stephanie E. Cohen, Julia C. Dombrowski, Cole Grabow, Grace C. Haser +15 more

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4

N/A

1.3DataRank · unranked

56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants

AIDS Patient Care and STDs(2024)10.1089/apc.2023.0289

N/A

1.2DataRank · unranked

26 citations

Rodney Perkins, Clare Brown, Chase A. Cannon, Carolina B. López, Alison Cohee +8 more

Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad209

N/A

0.483DataRank · unranked

24 citations

Nadine Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer +31 more

Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention

Clinical Infectious Diseases(2024)10.1093/cid/ciae183

N/A

0.372DataRank · unranked

6 citations

Yoninah Cramer, Marjorie Z. Imperial, Susan L. Rosenkranz, Anchalee Avihingsanon, Roberto C. Arduino +7 more

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications(2025)10.1038/s41467-025-55931-w

N/A

0.345DataRank · unranked

9 citations

Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Jing Wang +43 more

Evidence-Informed Provision of Doxycycline Postexposure Prophylaxis for Prevention of Bacterial Sexually Transmitted Infections

Clinical Infectious Diseases(2024)10.1093/cid/ciae527

N/A

0.312DataRank · unranked

7 citations

Deborah Donnell, Cole Grabow, Stephanie E. Cohen, Chase A. Cannon, Clare Brown +4 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad323

N/A

0.208DataRank · unranked

3 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +80 more

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial

medRxiv(2023)10.1101/2023.01.31.23285306

N/A

0.104DataRank · unranked

1 citations

Nadine Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer +31 more

Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C

Clinical Infectious Diseases(2025)10.1093/cid/ciaf305

N/A

0.104DataRank · unranked

1 citations

Min‐Hee Kang, Triin Umbleja, Estêvão Portela Nunes, Kristen Marks, Anne F. Luetkemeyer +67 more

Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: an individual patient data meta-analysis

medRxiv(2024)10.1101/2024.04.07.24305445

N/A

0.104DataRank · unranked

1 citations

Melike Hazal Can, Tefera Agizew, Andrew F. Auld, María Elvira Balcells, Stephanie Bjerrum +21 more

Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistome

Research Square(2024)10.21203/rs.3.rs-4243341/v1

N/A

0DataRank · unranked

4 citations

Victoria Chu, Abigail Glascock, Deborah Donnell, Cole Grabow, Clare Brown +10 more

Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

medRxiv(2023)10.1101/2023.06.06.23290973

N/A

0DataRank · unranked

0 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +31 more

Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis

PLoS Medicine(2025)10.1371/journal.pmed.1004502

N/A

0DataRank · unranked

7 citations

Melike Hazal Can, Tefera Agizew, Andrew F. Auld, María Elvira Balcells, Stephanie Bjerrum +21 more

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis

Pharmacogenetics and Genomics(2025)10.1097/fpc.0000000000000562

N/A

0DataRank · unranked

3 citations

Anne F. Luetkemeyer, Marjorie Z. Imperial, Rodney Dawson, Yoninah Cramer, Sue Rosenkranz +10 more

Ethical Considerations in Implementing Doxycycline Postexposure Prophylaxis for the Prevention of Bacterial Sexually Transmitted Infections

Sexually Transmitted Diseases(2023)10.1097/olq.0000000000001907

N/A

0DataRank · unranked

7 citations

Holly A. Taylor, Laura H. Bachmann, Lindley A. Barbee, Seán Cahill, Connie Celum +9 more

Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae – Authors' reply

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00235-x

N/A

0DataRank · unranked

2 citations

Deborah Donnell, Connie Celum, Anne F. Luetkemeyer

Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections

Clinical Infectious Diseases(2024)10.1093/cid/ciae062

N/A

0DataRank · unranked

38 citations

Moira McNulty, Maria Pyra, Jade Pagkas-Bather, José I. Gutierrez, Jim Pickett +7 more

Daily Second-generation Integrase Strand Inhibitors and Short-course Tuberculosis Preventive Therapy: What More Do We Need to Know?

Clinical Infectious Diseases(2023)10.1093/cid/ciad726

N/A

0DataRank · unranked

0 citations

Anne F. Luetkemeyer, Gabriel Chamie